Stock Alert: Fulgent Genetics Up 20% On COVID-19 Testing Deal For NY Schools

Shares of Fulgent Genetics Inc. (FLGT) are currently gaining nearly 20% on Thursday morning. The other day, the genetic testing services company said it would supply COVID-19 testing to hundreds of thousands of students in collaboration with New York City Health and Hospitals at nearly 1,600 locations.

FLGT is currently trading at $34.52, up $6.14 or 21.28%, on the Nasdaq.

The California-based company will supply its RT-PCR at-home test, approved under US FDA emergency use authorization, for students, as they return to school beginning September.

Separately, Fulgent also announced that beginning September 28th, all patients tested for COVID-19 by Fulgent Genetics will also receive results for Influenzas A and B.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Green Field Farms Dairy has recalled its Whole Chocolate Milk product as a laboratory analysis indicated that the product was not effectively pasteurized, the U.S. Food and Drug Administration announced. The recall involves 1,242 units of the Whole Chocolate Milk with an expiration date of September 29, 2021. General Motors will start replacing defective battery modules in Chevrolet Bolt EVs and EUVs with new modules. The replacement battery modules will be shipped to dealers as soon as mid-October, the automaker said in a statement. CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing.
Follow RTT